Impact BioMedical Insider Sale Spurs Market Rally, Investors Eye FDA Milestone
Impact BioMedical insider sale: 50,000 shares at $0.65 amid 27% rally. Learn how regulatory milestones, partnership deals, and market volatility shape its high‑risk, high‑potential biotech upside.
3 minutes to read